ARCHIVES

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Blochs Plan To Fund National Network Of “Cancer Survivor Parks” In Every City

August 3, 1990

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

October 26, 1984

Breslow Says NCI, Centers, States Should Collaborate On Cancer Control

June 1, 1984

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

October 31, 2014

Gallo Inquiry Complete; NCAB’s AIDS Committee Plans Q&A Session

June 12, 1992

Women Who Concieve Using Fertility Drugs Have a Higher Risk Of Breast Cancer Than Non-Users

July 27, 2012